1) 2015 New Drug Approvals Hit 66-Year High! – Forbes, 1/4/2015
2015 has been a remarkable year for pharmaceutical innovation. What would have been a dream (or perhaps a delusion) a few years ago has happened.
2) Key takeaways from the state’s new digital-health initiative – BBJ, 1/7/2016
Elected officials and key stakeholders in the Bay State’s health care and technology sectors gathered at Boston Childrens Hospital to unveil a new public-private partnership aimed at expanding the state’s role in the fast-emerging electronic-health care sector.
3) This Startup’s Painkiller Is Stronger Than Morphine and Non-Addictive – BostInno, 1/4/2016
From a very early age, we’re taught the evils of drug addiction. No one ever starts off their lives aspiring to be an addict, and there’s a perception that anyone who is addicted to drugs belongs in the dregs of society.
4) Eight Milestones Of 2015 In The War On Cancer – Forbes, 1/1/2016
Fourteen the 45 novel drugs that hit the market in 2015 were approved by the U.S. Food & Drug administration to treat cancer—offering new hope for patients battling multiple myeloma, colon cancer, thyroid cancer and many other forms of the disease. It was a good year for pharma companies working in oncology, to be sure.
5) 30 Under 30: Meet The Entrepreneurs Who Are Fixing The Healthcare System – Forbes, 1/4/2016
These researchers and entrepreneurs aren’t just improving how we do healthcare. They’re reinventing it.